Tue, March 8, 2022

Michael King Maintained (ANAB) at Strong Buy with Increased Target to $46 on, Mar 8th, 2022

Michael King of HC Wainwright & Co., Maintained "AnaptysBio, Inc." (ANAB) at Strong Buy with Increased Target from $43 to $46 on, Mar 8th, 2022.

Michael, nor any peers, have made any analyst calls on ANAB in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30